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Much interest has been generated by recent reports
on the discovery of circular (i.e. head-to-tail cyclized)
proteins in plants. Here we report the three-dimensional
structure of one of the newest such circular proteins,
MCoTI-II, a novel trypsin inhibitor from Momordica co-
chinchinensis, a member of the Cucurbitaceae plant
family. The structure consists of a small b-sheet, several
turns, and a cystine knot arrangement of the three di-
sulfide bonds. Interestingly, the molecular topology is
similar to that of the plant cyclotides (Craik, D. J., Daly,
N. L., Bond, T., and Waine, C. (1999) J. Mol. Biol. 294,
1327–1336), which derive from the Rubiaceae and Vio-
laceae plant families, have antimicrobial activities, and
exemplify the cyclic cystine knot structural motif as
part of their circular backbone. The sequence, biological
activity, and plant family of MCoTI-II are all different
from known cyclotides. However, given the structural
similarity, cyclic backbone, and plant origin of MCoTI-
II, we propose that MCoTI-II can be classified as a new
member of the cyclotide class of proteins. The expansion
of the cyclotides to include trypsin inhibitory activity
and a new plant family highlights the importance and
functional variability of circular proteins and the fact
that they are more common than has previously been
believed. Insights into the possible roles of backbone
cyclization have been gained by a comparison of the
structure of MCoTI-II with the homologous acyclic tryp-
sin inhibitors CMTI-I and EETI-II from the Cucurbita-
ceae plant family.
Over the last few years a number of small disulfide-rich
proteins that have a head-to-tail cyclized peptide backbone
have been discovered in plants. These circular proteins include
kalata B1 (1), the circulins (2, 3), and cyclopsychotride A (4)
from the Rubiaceae family, and various peptides from plants in
the Violaceae family (3, 5–8). They contain ;30 amino acids,
including six highly conserved cysteine residues that form
three structurally important disulfide bonds. The latter con-
tribute to the molecules having well defined and stable three-
dimensional structures (8). Because of their well defined struc-
tures and potent biological activities, the molecules may be
regarded as miniproteins. We recently proposed that the
known circular proteins most likely form part of a large family
of proteins that we refer to as the plant cyclotides (8). They
contain the conserved cysteine spacing CX3-CX4-CX4–7-CX1-
CX4–5-CX5–7 within their circular backbone.
The plant cyclotides display a diverse range of biological
activities ranging from uterotonic action (kalata B1 (1)), to
anti-HIV activity (circulins (2)), to hemolytic activity (5, 9, 10),
and inhibition of neurotensin binding (cyclopsychotride A (4)).
Although their precise role in plants has not yet been reported,
it appears that they are most likely present as defense mole-
cules. All of their biological activities in mammalian systems
seem to be related in one way or another to membrane inter-
actions, a common feature of plant defense molecules. Recently
the cyclotides have also been reported to display a wide range
of anti-microbial activities against Gram-positive and Gram-
negative bacteria, and against certain fungi (9), further en-
hancing the likelihood that they are indeed plant defense
molecules.
The three-dimensional structures of three members of the
plant cyclotide family have now been determined, including the
prototypic member kalata B1, the first macrocyclic peptide for
which a full three-dimensional structure was determined (1),
circulin A (11), and cycloviolacin O1 (8). The structures are all
highly conserved and contain a distorted triple stranded
b-sheet, perhaps better described as a well defined b-hairpin
with a third strand forming a b-bulge (8). The three disulfide
bonds are arranged in a so called cystine knot, in which an
embedded ring in the structure formed by two disulfide bonds
and their connecting backbone segments forms a ring that is
penetrated by the third disulfide bond (12–15). Although a
seemingly unlikely structural motif, the cystine knot has now
been seen in a variety of small disulfide-rich proteins from both
the plant and animal kingdoms (15), and seems to be associated
with exceptionally high stability and resistance to proteolytic
cleavage of molecules containing it. This is particularly so for
the cyclotides, which contain a cyclic cystine knot motif (8).
Recently Hernandez et al. (16) reported two new macrocyclic
peptides derived from Momordica cochinchinensis, a vine plant
from the Cucurbitaceae plant family. The two molecules,
named MCoTI-I and MCoTI-II are trypsin inhibitors and com-
prise 34 amino acids, a cyclized peptide backbone, and three
disulfide bonds. They are homologous to a large range of open-
chain trypsin inhibitors from plants (16), but are the first
reported macrocyclic trypsin inhibitors (although note that a
smaller, single disulfide-containing cyclic trypsin inhibitor was
recently reported from sunflower seeds (17)). This exciting dis-
covery supports our view that macrocyclic peptides are much
* This work was supported in part by a grant from the Australian
Research Council (to D. J. C.). The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1IB9) have been
deposited in the Protein Data Bank, Research Collaboratory for Struc-
tural Bioinformatics, Rutgers University, New Brunswick, NJ (http://
www.rcsb.org/).
hS The on-line version of this article (available at http://www.job.org)
contains Tables 1–3 and Fig. 1.
‡ Australian Research Council Senior Fellow. To whom correspond-
ence should be addressed: Institute for Molecular Bioscience, Univer-
sity of Queensland, Brisbane, QLD 4072, Australia. Tel.: 61-7-3365-
4945; Fax: 61-7-3365-2487; E-mail: d.craik@imb.uq.edu.au.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 25, Issue of June 22, pp. 22875–22882, 2001
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 22875
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
more common in plants than has previously been realized, and
that many more are likely to be discovered over coming years.
The sequences of the two new trypsin inhibitors, MCoTI-I
and MCoTI-II, show little homology with the known plant
cyclotides apart from the six-conserved cysteine residues and
the macrocyclic peptide backbone, as seen by a comparison of
MCoTI-II and kalata B1 in Fig. 1. Note that because the mol-
ecules are cyclic the choice of numbering of residue 1 is arbi-
trary but throughout the text we have adopted the numbering
scheme used by Hernandez et al. (16). In addition, we adopted
our earlier nomenclature for defining the six cysteine residues
(labeled I-VI) and the six backbone loops that make up the
sequences between the cysteine residues (loops 1–6). This
numbering scheme is defined in Fig. 1.
The three-dimensional structure of MCoTI-II has been mod-
eled (16) based on its sequence similarity to open chain trypsin
inhibitors, however, no experimental determination of the
three-dimensional structure of the new macrocyclic peptides is
available. We were interested to see whether this class was
similar to the plant cyclotides and contained the cystine knot
motif. We therefore isolated and purified a sample of MCoTI-II
from M. cochinchinensis and herewith report the three-dimen-
sional structure determined using NMR spectroscopy and sim-
ulated annealing calculations.
One of the motivating factors for examining structures of this
class of molecules is that they are known to be highly stable
and, indeed, in the case of kalata B1, are apparently orally
bioavailable, a most unusual feature for peptide-based mole-
cules. This bioavailability is demonstrated in the native medi-
cine applications of Oldenlandia affinis, the plant from which
kalata B1 is derived. Women of certain tribes in the Congo
region ingest a tea made from the plant to accelerate labor (18).
The possibility of using the cyclic cystine knot macrocyclic
disulfide knotted framework as a template in pharmaceutical
design applications is thus very attractive (19). The three-
dimensional structure reported here provides a basis for these
applications, as well as demonstrating that the new trypsin
inhibitors form part of the cyclotide family.
EXPERIMENTAL PROCEDURES
Isolation and Purification of MCoTIs—Ripe frozen fruits of M. co-
chinchinensis were purchased from a Vietnamese store in Melbourne,
Australia. The dormant seeds were homogenized using a blender and
extracted with 20 mM sodium acetate. The fine debris was removed
using a cotton plug. 40% Acetone, H2O (v/v) solution was added to the
crude extract at a ratio of ;1:1 (v/v). Acetone was reduced using a
rotary evaporator after which the mixture was cooled down to 4 °C and
centrifuged for 30 min. The supernatant was then passed through a
filter before purification using preparative RP-HPLC1 on a Vydac C18
column. Gradients of 0.1% aqueous trifluoroacetic acid and 90% aceto-
nitrile, 0.09% trifluoroacetic acid were employed with a flow rate of 8
ml/min, and the eluant monitored at 230 nm. Further purification was
performed using semipreparative RP-HPLC on a Vydac C18 column.
The final purity was examined with analytical RP-HPLC and electro-
spray mass spectrometry.
NMR Spectroscopy—Samples for 1H NMR measurements contained
1 mM peptide in either 99.99% D2O or 90% H2O, 10% D2O (v/v) at pH
3.5. Spectra were recorded at 288, 293, and 298 K on a Bruker AVANCE
750 MHz spectrometer. The two-dimensional NMR experiments em-
ployed were similar to those used for the related cyclic peptide circulin
A (11) and included DQF-COSY, E-COSY, and TOCSY using a
MLEV-17 spin lock sequence with a mixing time of 80 ms, and NOESY
with mixing times of 150, 200, 250, and 300 ms. Slowly exchanging NH
protons were detected by acquiring a series of one-dimensional and
TOCSY spectra of the fully protonated peptide immediately following
dissolution in D2O.
3JaH-bH coupling constants were measured from
E-COSY spectra and 3JNH-aH coupling constants were measured from
DQF-COSY spectra, transformed over the fingerprint region to 8 3 1 K.
Spectra were processed according to methods given in Daly et al. (11).
Chemical shifts were referenced to sodium 2,2-dimethyl-2-silapentane-
5-sulfonate at 0.00 ppm and the spectra were analyzed and assigned
using XEASY (20).
Structural Restraints—Peak volumes were integrated using XEASY
and distance restraints obtained from CALIBA with appropriate
pseudoatom corrections. Backbone dihedral restraints were inferred
from 3JNH-aH coupling constants, with f restrained to 120 6 30° for a
3JNH-aH greater than 9 Hz, and 65 6 30° for a
3JNH-aH less than 6 Hz.
Stereospecific assignments and x1 angle restraints were obtained for 7
residues using coupling constants measured in an ECOSY spectrum in
conjunction with NOE intensities. Both proline residues were in the
trans-conformation based on characteristic NOEs. The b-methylene
protons of the proline residues were stereospecifically assigned based
on the peak intensities in the NOESY spectra. Six hydrogen bonds were
determined based on slow exchange data and preliminary structure
calculations. Hydrogen bond restraints of 1.7–2.2 and 2.7–3.2 Å were
used for the HNi-Oj and Ni-Oj distances, respectively.
Structure Calculations—Three-dimensional structures were initially
calculated using DYANA (21) to check NOE restraints for violations
and resolve ambiguous cross-peaks. Dihedral angle and hydrogen bond
restraints were subsequently included in these structure calculations.
The final 50 structures were generated using a torsion angle dynamics
protocol (22, 23) within the program X-PLOR 3.851 (24). Refinement of
these structures was achieved using the conjugate gradient Powell
algorithm with 1000 cycles of energy minimization (25) in a refined
forcefield based on the program CHARMm (26). Structures were ana-
lyzed using PROMOTIF (27) and PROCHECK-NMR (28).
RESULTS
The seeds of M. cochinchinensis were extracted with sodium
acetate as described previously (16) and the extract was puri-
fied using RP-HPLC. Various peptides were isolated and their
molecular weights were analyzed by mass spectrometry. Mo-
lecular weights consistent with the previously isolated macro-
cyclic peptides, MCoTI-I (3480) and MCoTI-II (3453), were
present in addition to isomers corresponding to the b-aspartyl
(3453) and succinimide (3435.5) forms of MCoTI-II (16). In the
previous study (16) the peptide bond between Asp-4 and Gly-5
was shown to be susceptible to succinimide and b-aspartyl
formation and this was confirmed in the current study.
Sufficient quantities of MCoTI-II and its b-aspartyl isomer
were isolated to allow characterization with NMR spectros-
copy. Amino acid sequencing was performed essentially using
NMR spectroscopy, as the spin systems observed in TOCSY
spectra and the sequential connectivities observed in NOESY
spectra were completely consistent with those of the published
1 The abbreviations used are: RP-HPLC, reversed-phase high per-
formance liquid chromatography; MCo, Momordica cochinchinensis;
TOCSY, two-dimensional total correlation spectroscopy; NOE, nuclear
Overhauser effect; NOESY, two-dimensional NOE spectroscopy; DQF-
COSY, double quantum filtered correlation spectroscopy; RMSD, root
mean square deviation.
FIG. 1. Sequence alignment of MCoTI-II with kalata B1. The
disulfide connectivities are represented at the top of the diagram and
the b-sheet regions of kalata B1 are represented as arrows. Cysteine
residues are numbered by Roman numerals. The loops (regions between
successive Cys residues) are numbered at the bottom of the diagram
based on the numbering scheme previously used for kalata B1 (8). The
numbering scheme used for MCoTI-II throughout the text is based on
the paper describing the isolation of this peptide (16). Residue 1 for this
numbering scheme is shown on the sequence of MCoTI-II.
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sequence (16). Assignments were made using established tech-
niques (29) and the 1H chemical shifts are supplied as supple-
mentary material. The fingerprint regions of a TOCSY and
NOESY spectra of MCoTI-II are given in Fig. 2. The amide
region is very well dispersed and this facilitated the assign-
ment process. The excellent dispersion and large number of
cross-peaks in the NOESY spectrum also provided the first
indication of a well defined three-dimensional structure.
As the b-aspartyl homologue of MCoTI-II has an identical
molecular weight to the normal (a-aspartyl) isomer, NMR spec-
troscopy was used to discriminate between these molecules.
Only one form (i.e. that eluting later on HPLC) displayed the
expected sequential NOE connectivities (Fig. 3a) between res-
idues 4 and 5, which strongly suggests this form contains the
“normal” peptide backbone. Comparison of the aH chemical
shifts of both isomers (Fig. 3b) suggests that the molecules
have very similar structures, with the exception of the region
surrounding residues 4 and 5. Having established the similar-
ity of the two forms, in the current study we have determined
the three-dimensional structure of the isomer of MCoTI-II with
the a-Asp-4 configuration.
Analysis of the NOE data, coupling constants and slow ex-
change amide protons (Fig. 4a) allowed the secondary structure
to be elucidated as shown in Fig. 4b. A b-hairpin is present
within residues 26–34 and there are b-sheet interactions be-
tween this hairpin and residues 13–15. An analysis of second-
ary shifts (i.e. the differences between observed chemical shifts
and random coil values (30)) supported this interpretation of
the secondary structure and indicated the presence of
b-strands but no helical regions.
The three-dimensional structure of MCoTI-II was deter-
mined using torsion angle dynamics coded within the program
XPLOR (24). The disulfide bonding pattern had not been de-
termined chemically and so it was important to define this
using NMR methods. For small disulfide-rich molecules in
which the disulfide bonds form a compact core such an ap-
proach is often the only one available due to the difficulty of
obtaining suitable cleavage products. Preliminary structure
calculations without any disulfide bonds included as restraints
were consistent with the disulfide connectivities being identical
to those in linear squash trypsin inhibitors (31) previously
characterized and those in the cyclotide peptides (8) (i.e. Cys
I-Cys IV, Cys II-Cys V, and Cys III-Cys VI). This conclusion
was based on an analysis of distances between all possible pairs
of S atoms in the preliminary structures (Supplementary Ma-
terial). This clearly shows that the optimal S-S pairing corre-
sponds to the Cys I-Cys IV, Cys II-Cys V, and Cys III-Cys VI
connectivity. Subsequent structure calculations were per-
formed with the disulfide bonds formally connected in this way
and these yielded structures of low energy and excellent cova-
lent geometry. Combined with the consistency with the homol-
ogous squash inhibitors and the plant cyclotides this was taken
as strong evidence for the proposed disulfide connectivity. Hy-
drogen bonds were also inferred from the preliminary structure
calculations in conjunction with the slow exchange data, and
all were consistent with the b-sheet shown in Fig. 4b.
The family of structures for MCoTI-II is well defined over
most of the molecule (residues 8–34), however, there are few
medium or long range NOEs for the first seven residues and
this results in a lack of definition in this region (Fig. 5a). This
is reflected in the angular order parameters (Supplementary
Material) that are generally .0.9 for the f and c angles for
residues 8–34, but vary between 0.2 and 0.9 for residues 1–7.
Geometric and energetic statistics that define the 20 lowest
energy structures are given as supplementary data. The
RMSD’s for residues 8–34 are 0.70 6 0.17 and 1.86 6 0.38 Å for
FIG. 2. NMR spectra of MCoTI-II. Regions of the 80-ms TOCSY
spectrum (top) and 200 ms NOESY spectrum of MCoTI-II in 90% H2O,
10% D2O at 293 K. Spin systems are shown in the TOCSY spectrum and
the sequential connectivities in the aH-NH region of the NOESY spec-
trum. The one-letter code for amino acids combined with the residue
number is used to denote assignment. The excellent signal dispersion is
indicative of a well defined three-dimensional structure.
FIG. 3. Comparison of the a and b aspartyl isomers of MCoTI-
II. a, structure of a and b aspartic acid residues and sequential NOEs
expected to be observed in the a-Asp form. b, comparison of the a-proton
chemical shifts of the two isomers of MCoTI-II. The fact that the
differences occur only near residue Asp-5 suggests that isomerization of
this residue (a/b aspartic acid) is responsible for the differences be-
tween the two isolated peptides.
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the backbone atoms and all heavy atoms, respectively. The
corresponding values are 0.45 6 0.11 and 1.56 6 0.22 Å for
superimposition over residues 12–34.
The major features of the three-dimensional structure are a
b-sheet region and several turns. Analysis of the secondary
structure elements in the final family of calculated structures
with PROMOTIF (27) reveals a g turn between residues 18 and
20 and b-turns between residues 15–18 and 22–25. A b-hairpin
is formally recognized by PROMOTIF between residues 26 and
34, as expected from the preliminary secondary structure anal-
ysis, and a type I b-turn between residues 28 and 31 connects
the strands. The b-sheet interactions observed between the
hairpin and residues 13–15 (Fig. 4b) are not formally recog-
nized by PROMOTIF as part of a triple-stranded b-sheet. How-
ever, this is also found for other related small disulfide-rich
peptides and is hence not surprising. In the plant cyclotides
(19) the third b-strand is only loosely connected to the well
defined b-hairpin. Thus, despite the presence of NOEs and
slowly exchanging amide protons characteristic of b-sheets, the
orientations of the strands in the structure calculations are
such that they are not formally recognized as part of a triple-
stranded b-sheet in all of the structures.
The disulfide bonds of MCoTI-II form a cystine knotted
structure similar to that in the plant cyclotides. In this ar-
rangement the embedded ring formed by Cys I-Cys IV and Cys
II-Cys V and their connecting backbone segments is threaded
by the third disulfide bond, Cys III-Cys VI. A schematic repre-
sentation of the secondary structure and the cystine knot of
MCoTI-II is given in Fig. 5b.
Since the peptide backbone of MCoTI-II is cyclic, a conven-
ient way to describe the structural features is in terms of the
six segments, or loops, that are flanked by pairs of successive
Cys residues. Fig. 6 shows the backbone considered in this way
and highlights several features of the derived structures, in-
cluding the location of the three b-strands and the various
turns. The disulfide bond connectivity is also shown. Loop 1,
between Cys I and Cys II contains a highly positively charged
(13) hexapeptide segment which, based on homology with cor-
FIG. 4. NMR information on the secondary structure of MCoTI-II. a, summary of the sequential and medium range NOE information,
3JNH-aH coupling constants and slow exchange NH data for MCoTI-II. The top three lines give the sequential NOE data, with the height of the bars
indicating the relative NOE strength (strong, medium, or weak). Open and filled squares represent 3JNH-aH coupling constants of $9 and #6.0 Hz,
respectively. Filled circles indicate slow exchange amide protons. b, schematic representation of the b-sheet region of MCoTI-II showing the
interstrand NOEs (arrows); aa NOEs across the sheet are shown as solid lines and potential hydrogen bonds are shown as broken lines.
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responding acyclic trypsin inhibitors, comprises the putative
active site residues Lys/Ile. Loop 2 contains two positive and
two negative charges and includes a b-turn between residues
15–18 and a g turn between residues 18 and 20. Loop 3 con-
tains no charged residues but incorporates a b-turn within its
PGA sequence. Loop 4 contains a single amino acid (I) and is
incorporated within one of the b-strands that make up the
b-hairpin. It is followed by loop 5, which contains a type I
b-turn and leads into loop 6, which incorporates the second
strand of the b-hairpin. In the final folded structures the di-
sulfide bonds “pinch” the circular backbone and loops 2 and 5
are drawn very close to one another.
Loop 6 protrudes from the structure more than any of the
other loops and is also the most disordered. Fig. 5 shows that
individual structures vary widely in their placement of this
loop relative to the core of the molecule. This may reflect
intrinsic flexibility or simply a lack of NOEs defining this
region. Loop 6 contains a high Gly content and hence the
number of possible protons, and hence NOEs, is reduced rela-
tive to larger amino acids. To assess whether it was lack of
NOEs, or flexibility that results in the disorder for loop 6, the
chemical shift separation of the b-protons of various amino acid
side chains was examined. In general, rigid conformations are
associated with widely separated b-proton shifts while, in con-
trast, degenerate b-proton shifts can be indicative of conforma-
tional averaging. For example, in an analysis of acyclic permu-
tants of kalata B1, those permutants with decreased stability,
based on amide exchange rates, displayed a decreased shift
dispersion for cysteine b-protons (32).
Analysis of the b-proton chemical shift separations for the
six cysteine residues of MCoTI-II supports the proposal of
flexibility in loop 6. The disulfide bond connecting residues 8 to
25 is the closest disulfide bond to the disordered region and the
b-protons are essentially degenerate for both of these residues,
suggesting conformational averaging in this region of the mol-
ecule. By contrast, the b-shifts for the remaining four cysteine
residues are separated by 0.17 to 0.34 ppm and correspond to
well defined regions of the molecule. The flexibility in this
putative linker region was predicted in the model determined
by Hernandez et al. (16). The model also suggested contacts
between Gly-6 and Ala-24, and indeed NOEs are observed
between these residues in our study. However, the possible
hydrogen bonding predicted between Ser-1 and Arg-28 was
observed in very few of the NMR structures.
A comparison of MCoTI-II with the trypsin inhibitor CMTI-I
(31) and the plant cyclotide, kalata B1, is given in Fig. 7. It is
apparent the proteins possess similar topologies. For example,
the backbone atoms of the cysteine residues of MCoTI-II and
CMTI-I superimpose with an RMSD of 0.98 Å. The equivalent
FIG. 5. Three-dimensional structure of MCoTI-II. a, stereoview of the family of 20 lowest energy structures for MCoTI-II. The structures are
superimposed over the backbone atoms of residues 12–33 and the disulfide bonds are shown in pink. b, ribbon representation of the secondary
structure elements of MCoTI-II with the disulfide connectivities shown in stick form. Diagrams were generated using MOLMOL (39).
FIG. 6. Schematic representation of MCoTI-II structural fea-
tures. The six cysteine residues are shown as filled circles and labeled
I-VI, starting at the sequence CPKI. The disulfide connectivities are
shown as lines connecting the cysteine residues along the circular
backbone. The position of the turns, b-strands, and backbone loops are
indicated, along with the location of charges.
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RMSD for kalata B1 and MCoTI-II is much higher (6.02 Å)
because of the differences in spacings between the cysteine
residues. However, when superimposed over the backbone at-
oms of the four cysteine residues that make up the ring of the
cystine knot the RMSD value is 1.83 Å. Another trypsin inhib-
itor, EETI-II (33), also has a similar structure to MCoTI-II and
superimposes with an RMSD of 1.37 Å over the backbone atoms
of the cysteine residues.
DISCUSSION
In the current study we have determined the three-dimen-
sional structure of MCoTI-II, a 34-amino acid trypsin inhibitor
from M. cochinchinensis. It has the unusual feature of a head-
to-tail cyclized peptide backbone, and thus joins the ranks of an
increasing number of small circular proteins discovered over
the last five years. The main element of secondary structure is
a b-hairpin and associated cystine knot framework. A third
strand of b-sheet is loosely connected with this hairpin and the
molecule also contains several turns. The overall fold is very
similar to that of the squash trypsin inhibitors EETI-II and
CMTI-I. Both have high sequence homology with MCoTI-II but
are “conventional” proteins in that they lack the head-to-tail
cyclization of MCoTI-II.
The similarity of the overall fold of the cyclic inhibitor to
those of linear homologues raises the question of what is the
advantage/biological role of cyclization? Several possibilities
could be contemplated, including factors relating to conforma-
tional or dynamic stabilization, changes in physicochemical
properties, addition of new functionality, or protection from
proteolytic cleavage. We examine these possibilities in turn and
then compare this newly discovered cyclic plant protein with
the previously reported cyclotide family (8) of macrocyclic knot-
ted peptides.
Possible conformational effects of cyclization could include
stabilization of the active site residues into a preferred confor-
mation for binding, or entropic stabilization associated with
tethering the ends of linear homologues. The termini of small
peptides are often disordered and hence contribute to unfavor-
able entropic losses on binding to target proteins. Cyclization
can potentially reduce such losses by reducing mobility near
the termini. However, this does not seem to be the primary role
of cyclization in the case of MCoTI-II, since the putative linker
involved in cyclization is in fact quite flexible. While the gene
coding for MCoTI-II has yet to be reported, the mature peptide
is likely to be derived from a larger precursor protein, process-
ing of which results in the ligation of N- and C-terminal regions
to form loop 6. This is based on analogy with the gene for the
related open chain peptide TGTI-II from Towel gourd (34),
whose sequence is consistent with loops 1–5 forming a contig-
uous region of the peptide chain. From an entropic perspective
it is therefore surprising that the introduced loop 6 linker
region is highly disordered, and apparently flexible, in the
cyclic protein. The assumption that the disorder in this region
reflects flexibility, rather than simply a lack of NOEs is sup-
ported by an analysis of chemical shift dispersion of b-methyl-
ene protons.
Given that entropic factors do not explain the role of cycli-
zation it was of interest to see if there might be specific con-
formational changes associated with cyclization that are im-
portant in a static rather than dynamic sense, e.g. in stabilizing
a particular binding conformation. It has been suggested that
the mechanism of inhibition of the MCo peptides is identical to
that for other squash trypsin inhibitors, based on the sequence
conservation in the putative inhibitory loop (16). The local
conformations of the residues presumed to be at the active site
are summarized in Table I for MCoTI-II and a range of linear
homologues, both in solution and complexed to trypsin. Com-
parison of a linear squash inhibitor, CMTI-I (31), with the
cyclic MCoTI-II reveals similar backbone angles in solution,
with the most significant difference being in the c angle of the
P1 residue (Lys-10) and to a lesser extent in the f angle of the
P19 residue. The solution structures of MCoTI-II and CMTI-I
are also very similar to the bound structures listed in Table I
with the exception of the c angle of the P1 residue. The lack of
a major conformational change between MCoTI-II and linear
homologues, either in solution or bound states, suggests that
cyclization does not play a significant role in determining the
active site conformation.
The final inhibitor listed in Table I, sunflower trypsin inhib-
itor I differs significantly from the others in that it is much
smaller (14 residues), contains a single disulfide bond and
unlike all except MCoTI-II, is cyclic (17). It is a particularly
potent trypsin inhibitor despite this small size and hence pro-
vides an opportunity to assess the essential residues for activ-
ity. Its three-dimensional structure in complex with bovine
b-trypsin has been determined using x-ray crystallography (17)
and the active site residues are in similar positions to those
observed for the other squash inhibitors (Table I). The fact that
potent trypsin inhibition can be obtained with such a small
inhibitor is consistent with the fact that peripheral regions of
the MCoTI-II inhibitor are not essential for binding activity
and function, and hence play other roles. Conformational or
entropic roles for the loop 6 linker region have been discounted
and hence factors relating to additional functionality or modu-
lation of biophysical properties can be considered.
Another possible role for cyclization is that of protection from
proteolytic cleavage. Indeed, based on the discussion above,
which suggests that conformational or entropic roles are un-
likely, this seems the most likely function of cyclization in
MCoTI-II. Cyclization of small peptides is a well established
method used in the pharmaceutical industry to protect small
bioactive peptides against cleavage by in vivo exopeptidases.
Being a seed component, the MCoTI-II peptide most likely has
to survive intact for long periods prior to germination and its
function would be compromised if broken down by exopro-
FIG. 7. A comparison of the three-dimensional structures of CMTI-I (a), MCoTI-II (b), and kalata B1 (c). The disulfide bonds are shown
in yellow. The coordinates for EETI-II and kalata B1 were obtained from the Protein Data Bank. The overall structures are very similar for both
the trypsin inhibitors, CMTI-I and MCoTI-II, and for the plant cyclotide kalata B1. The diagram was generated using MOLMOL (39).
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teases. MCoTI-II has also been shown to be resistant to the
endoprotease thermolysin (16). This is analogous with the
plant cyclotide, kalata B1, which is resistant to a range of
enzymes including thermolysin, trypsin, and pepsin (1). In
general the naturally occurring cyclization of macrocyclic pep-
tides appears to be an effective means of stabilization, much as
is the case for small synthetic peptides.
Kalata B1 is just one member of what is now a large family
of cyclotides (8). Although MCoTI-II is of similar size (34 versus
29 amino acids) and cystine spacings, it displays no sequence
homology to the previously identified plant cyclotides. Never-
theless, the three-dimensional structure is similar, and con-
tains identical elements of secondary structure and the cystine
knot motif. The combined presence of a cyclic peptide backbone
and a cystine knot motif means that MCoTI-II fits into the
cyclic cystine knot structural framework (8, 15). The structural
similarity suggests the possibility that the cyclotides and the
Momordica peptides may be evolutionarily related, despite the
fact that they have different biological activities. Furthermore,
the observation of different biological activities for the various
members of the cyclotide family provides proof of the concept
that the cyclic cystine knot framework is particularly stable
and amenable to grafting of a range of different bioactivities
(15).
Fig. 7 shows that the size of the cystine knot motif in the
Momordica peptides is slightly different from those of the
known cyclotides and that the embedded ring in the structure
contains 11 amino acids rather than eight. This makes the
cystine knot slightly looser, however, the derived family of
structures are still very well defined over the core of the cystine
knot. By contrast, the linker region associated with backbone
cyclization appears much more flexible in the macrocyclic tryp-
sin inhibitors than in the previously reported plant cyclotides.
In the former case, the linker region consists of small hydro-
philic amino acids, whereas in the plant cyclotides the residues
are generally larger.
The previously reported cyclotides are characterized by their
long retention times on RP-HPLC. This is presumed to result
from a patch of surface-exposed hydrophobic residues (1). In
the case of kalata B1 we have shown that this patch arises after
formation of the native disulfide connectivities (10). The mac-
rocyclic peptides from MCo elute significantly earlier than the
cyclotides, suggesting decreased hydrophobicity. The MCo pep-
tides also contain many more charged residues, particularly
positively charged residues, than the cyclotides. The distribu-
tion of hydrophobic and charged residues for MCoTI-II is
shown in Fig. 8. Several of the hydrophobic residues are surface
exposed, presumably as a consequence of the core of the mole-
cule containing the disulfide bonds and leaving very little room
for other residues. These surface-exposed hydrophobic residues
appear mainly on one face of the molecule. The other face of the
molecule contains most of the positively and negatively charged
residues, with the positive residues clustered together. Clus-
tering of hydrophobic and cationic residues has previously been
found to be crucial for antimicrobial activity. The distribution
of these residues on the surface of MCoTI-II indicates that such
an activity may be possible for this molecule. This is supported
by the report that a preparation from M. cochinchinensis seeds,
which contained mainly MCoTI-II, exhibited antimicrobial
properties (16).
An interesting difference between the previously reported
cyclotides and the circular squash peptides is the absence of
linear counterparts for the cyclotides. Linear squash inhibitors
have been known for many years, however, so far there has
been no evidence for linear forms of the cyclotides. This may be
a consequence of the isolation techniques that have been em-
ployed to date, or may reflect highly efficient processing of the
cyclotides from putative linear precursors. Despite these differ-
ences between MCoTI-II and the plant cyclotides the similar
three-dimensional structure and cyclic backbone suggests they
can be regarded as part of the same family of proteins. Thus the
cyclotide family can be expanded to include the new cyclic
trypsin inhibitors MCoTI-I and MCoTI-II.
This expansion of the cyclotide family to include trypsin
inhibitors from the Cucurbitaceae family highlights the impor-
tance and functional variability of these peptides. The increas-
ing incidence of discoveries of naturally occurring circular pro-
teins coincides with the excitement currently associated with
TABLE I
Backbone angles (°) of MCoTI-II and selected trypsin inhibitors
Inhibitor
Residue
P3 P2 P1 P19 P29
f c f c f c f c f c
Solution state
MCoTI-II 2127 138 271 153 280 96 2119 153 2100 50
CMTI-I 267 123 274 137 259 237 263 130 275 129
Complexeda
MCTI-A 2137 113 255 148 291 35 283 146 284 126
CMTI-I 2122 110 257 149 290 30 284 150 286 114
CPTI-II 2126 108 257 149 294 39 285 147 287 122
LDTI 2141 153 270 155 291 38 289 151 2107 111
SFTI-I 2143 144 274 166 2104 33 288 174 2111 119
a The complexed structures were determined using x-ray crystallography with inhibitors complexed to trypsin. The Protein Data Bank accession
codes are CMTI-I (solution), 2cti (31); MCTI-A, 1mct (40); CMTI-I (complexed), 1ppe (41); CPTI-II, 2btc (42); SFTI-I, 1sfi (17); LDTI, 1anl (43).
FIG. 8. The three-dimensional structure of MCoTI-II shown in
CPK format. The negatively charged residues are in red, positively
charged in dark blue, hydrophobic residues in green, polar residues in
light blue, and cysteine residues in yellow. Surface exposed hydrophobic
residues appear mainly on one face and the other face contains most of
the positively and negatively charged residues. The views are rotated
180° about the vertical axis with respect to each other. The diagram was
generated using MOLMOL (39).
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the use of intein-based methods for the artificial production of
circular proteins (35–38).
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 Chemical shifts of MCoTI-II at 293 K 
 
Residue Number Atom Chemical shift 
1 HN 8.852 
1 HA 4.529 
1 QB 3.933 
2 HN 9.189 
2 HA1 4.443 
2 HA2 3.898 
3 HN 8.738 
3 HA 4.486 
3 QB 3.915 
4 HN 8.621 
4 HA 4.824 
4 HB2 2.947 
4 HB3 2.862 
5 HN 8.25 
5 HA1 4.11 
5 HA2 3.834 
6 HN 8.162 
6 QA 3.93 
7 HN 8.542 
7 HA 4.016 
7 HB 1.991 
7 QG1 0.943 
7 QG2 0.839 
8 HN 8.75 
8 HA 5.198 
8 QB 2.875 
9 HA 4.371 
9 HB2 2.31 
9 HB3 1.862 
9 HG2 2.007 
9 HG3 1.947 
9 QD 3.853 
10 HN 8.29 
10 HA 4.263 
10 HB2 1.829 
10 HB3 1.704 
10 QG 1.367 
10 QD 1.481 
10 QZ 7.542 
11 HN 7.752 
11 HA 4.387 
11 HB 1.795 
11 QG2 0.831 
11 QG1 1.356 
11 QD1 1.07 
12 HN 8.736 
12 HA 4.548 
12 QB 1.747 
12 HG 1.478 
12 QQD 0.767 
13 HN 8.946 
13 HA 4.592 
13 HB2 1.606 
13 HB3 1.566 
13 QG 1.414 
13 QD 1.754 
13 QZ 7.626 
14 HN 8.672 
14 HA 4.316 
14 HB2 1.643 
14 HB3 1.513 
14 QG 0.937 
14 QD 1.309 
14 QZ 7.474 
15 HN 8.437 
15 HA 4.888 
15 HB2 3.198 
15 HB3 2.932 
16 HN 9.399 
16 HA 4.443 
16 HB2 1.881 
16 HB3 1.729 
16 QG 1.63 
16 QD 3.186 
16 HE 7.308 
17 HN 8.081 
17 HA 4.742 
17 HB2 2.034 
17 HB3 1.793 
17 HG2 1.559 
17 HG3 1.457 
17 QD 3.153 
17 HE 7.169 
18 HN 9.348 
18 HA 4.118 
18 HB2 3.004 
18 HB3 2.83 
19 HN 8.217 
19 HA 4.303 
19 HB2 4.119 
19 HB3 3.834 
20 HN 7.739 
20 HA 4.634 
20 HB2 3.039 
20 HB3 2.965 
21 HN 8.16 
21 HA 5.063 
21 HB2 2.845 
21 HB3 2.674 
22 HA 4.624 
22 HB2 2.26 
22 HB3 1.938 
22 HG2 2.099 
22 HG3 2.041 
22 HD2 3.742 
22 HD3 3.43 
23 HN 8.525 
23 HA1 3.838 
23 HA2 3.758 
24 HN 8.451 
24 HA 4.537 
24 QB 1.366 
25 HN 8.325 
25 HA 4.59 
25 QB 3.199 
26 HN 9.083 
26 HA 4.427 
26 HB 1.928 
26 QG2 0.853 
26 QG1 1.071 
26 QD1 0.973 
27 HN 8.951 
27 HA 4.963 
27 HB2 2.811 
27 HB3 2.471 
28 HN 8.086 
28 HA 4.325 
28 HB2 2.507 
28 HB3 2.067 
28 HG2 1.751 
28 HG3 1.606 
28 QD 3.254 
28 HE 6.99 
29 HN 8.942 
29 QA 3.933 
30 HN 7.822 
30 HA 4.706 
30 HB2 3.331 
30 HB3 2.867 
30 HD21 7.59 
30 HD22 6.634 
31 HN 8.439 
31 HA1 3.999 
31 HA2 3.686 
32 HN 7.302 
32 HA 5.267 
32 HB2 3.073 
32 HB3 2.652 
32 QE 6.707 
32 QD 6.882 
33 HN 8.831 
33 HA 5.41 
33 HB2 3.057 
33 HB3 2.801 
34 HN 9.838 
34 HA1 4.522 
34 HA2 3.967 
 
 
 Angle order parameters 
 
Residue Phi Psi Chi 
1 0 0.686641 0.190624 
2 0.438999 0.174102 0 
3 0.905992 0.317279 3.22E-02 
4 0.530127 0.872661 0.32769 
5 0.440895 0.15847 0 
6 0.195358 0.332001 0 
7 0.926804 0.738738 0.998287 
8 0.899715 0.942151 0.990973 
9 0.993076 0.66344 0.991222 
10 0.948277 0.824178 0.627361 
11 0.946285 0.885756 0.440381 
12 0.870193 0.902477 0.564799 
13 0.923337 0.968606 0.749554 
14 0.959572 0.997557 0.996537 
15 0.993859 0.99268 0.998094 
16 0.988847 0.982025 0.539353 
17 0.975191 0.999065 0.998346 
18 0.998614 0.998642 0.997008 
19 0.995966 0.991155 0.999917 
20 0.987308 0.995956 0.997122 
21 0.999978 0.994449 0.975097 
22 0.996874 0.995309 0.99638 
23 0.998257 0.998799 0 
24 0.996468 0.994849 0 
25 0.995368 0.990971 0.892144 
26 0.984352 0.990422 0.907778 
27 0.982689 0.9903 0.998537 
28 0.978012 0.999727 0.997006 
29 0.996488 0.998573 0 
30 0.999322 0.993895 0.998298 
31 0.99076 0.995084 0 
32 0.994028 0.999107 0.987697 
33 0.99266 0.987696 0.964649 
34 0.871894 0 0 
 
 Structural statistics for the family of 20 MCoTI-II structures. 
Experimental restraints  
Intraresidue NOEs 101 
Sequential NOEs 107 
Medium range NOEs 41 
Long range NOEs 134 
Hydrogen bonds 12 
Dihedral angles 25 
Mean RMS deviations from experimental restraints  
NOE distances (Å) 0.017 ± 0.002 
Dihedral angles (•) 0.34 ± 0.01 
Mean RMS deviations from idealized covalent geometry  
Bonds (Å) 0.0075 ± 0.0003 
Angles (•) 2.14 ± 0.03 
Impropers (•) 0.18 ± 0.02 
Mean X-PLOR energies (kcal mol-1)  
ENOE 3.64 ± 0.89 
E
cdih 0.09 ± 0.06 
Ebond 3.97 ± 0.32 
E
angle 55.48 ± 2.32 
Eimproper 0.62 ± 0.12 
E
vdw -136 ± 4.96 
Atomic RMS differences (Å)c  
Backbone atoms (residues 8-34) 0.70 ± 0.17 
Heavy atoms (residues 8-34) 1.86 ± 0.38 
Backbone atoms (residues 12-34) 0.45 ± 0.11 
Heavy atoms (residues 12-34) 1.56 ± 0.22 
Ramachandran statistics (%)d  
Residues in most favoured regions 74.8  
Residues in additional allowed regions 23.8 
Resides in generously allowed regions 1.5 
Residues in disallowed regions 0 
aThe values in the table are the mean ± standard deviation. bIdealised geometry is defined 
by the CHARMM force field used in XPLOR. cAtomic RMS differences are the pairwise 
RMS difference for the family of structure. dProcheck_NMR was used to calculate the 
Ramachandran statistics. 
 
4.5
5.5
6.5
7.5
8.5
9.5
10.5
11.5
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Disulfide connectivity (set number)
R
M
SD
 (Å
)
tatistical analysis of S-S distances in structures generated for MCoTI-II without 
xplicit inclusion of disulfide bond restraints. The root mean square distance was 
alculated for the three S-S distances in a given set for a given structure. 
he plotted values are the RMS deviations of these values averaged over 20 structures. 
he disulfide sets were defined as follows: 
 8-15,21-25,27-33 2 8-15-21-27,25-33 3 8-15,21-33,25-27
 8-21,15-25,27-33 5 8-21,15-27,25-33 6 8-21,15-33,25-27
 8-25,15-21,27-33 8 8-25,15-27,21-33 9 8-25,15-33,21-27
0 8-27,15-21,25-33 11 8-27,15-25,21-33 12 8-27,15-33,21-25
3 8-33,15-21,25-27 14 8-33,15-25,21-27 15 8-33,15-27,21-25
et 8 corresponds to the connectivity homologous to that in linear squash inhibitors 
nd the cyclotides (Cys I-Cys IV, Cys II-Cys V, Cys III-Cys VI).
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